Review
Doxorubicin-polymer conjugates: further demonstration of the concept of enhanced permeability and retention
- PMID: 9918196
Item in Clipboard
Review
Doxorubicin-polymer conjugates: further demonstration of the concept of enhanced permeability and retention
Clin Cancer Res.
1999 Jan.
No abstract available
Comment on
-
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.Clin Cancer Res. 1999 Jan;5(1):83-94. Clin Cancer Res. 1999. PMID: 9918206 Clinical Trial.